Imatinib
Also known as Gleevec (us), Veenat (india)
Cancer & Oncology
Save $40/mo
A targeted therapy (tyrosine kinase inhibitor) used mainly for chronic myeloid leukaemia (CML) and some other cancers.
United States
$87
per month
India
$47
per month
You save
−46%save $40/mo · 46% cheaper
129.5K US scripts/yr$5.2M potential annual savings$11.3M US spend/yr
Drag to rotate · 3D structureC29H31N7O
SMILES: CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
Compare the price
US price$87per month
India price$47per month
You save$4046% less
Based on 30 tablets per month. US $2.90 vs India $1.56 per tablet.
Total over 1 periodSave $40$87 → $47
The bigger picture
Imatinib is filled about 129.5K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$11.3M
If sourced from India
$6M
Potential annual savings
$5.2M
−46%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.